Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-10-05

Clinical Trial Update: Valsartan Efficacy on Modest Blood Pressure Reduction in Acute Ischemic Stroke [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating valsartan for modest blood pressure reduction in patients with acute ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VALSARTAN (Valsartan)

Snippet

Sponsor: Hallym University Medical Center | Conditions: Acute Ischemic Stroke | Phase 4 | Status: UNKNOWN